Enovix (NASDAQ:ENVX) Shares Down 8.7% – What’s Next?

Enovix Corporation (NASDAQ:ENVXGet Free Report)’s stock price traded down 8.7% during mid-day trading on Tuesday . The stock traded as low as $5.24 and last traded at $5.1290. Approximately 814,270 shares were traded during mid-day trading, a decline of 87% from the average session volume of 6,403,803 shares. The stock had previously closed at $5.62.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ENVX shares. Benchmark dropped their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Craig Hallum lowered their target price on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Wells Fargo & Company set a $6.00 price target on Enovix in a research report on Thursday, March 12th. Bank of America started coverage on Enovix in a research report on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price target on the stock. Finally, Oppenheimer cut their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $12.64.

Read Our Latest Research Report on Enovix

Enovix Stock Down 10.1%

The firm’s 50-day simple moving average is $6.72 and its 200-day simple moving average is $6.53. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. The company has a market capitalization of $1.10 billion, a price-to-earnings ratio of -6.11 and a beta of 2.26.

Enovix (NASDAQ:ENVXGet Free Report) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same quarter in the prior year, the business earned ($0.15) earnings per share. The firm’s revenue for the quarter was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Sell-side analysts forecast that Enovix Corporation will post -0.79 earnings per share for the current year.

Institutional Trading of Enovix

A number of hedge funds have recently modified their holdings of ENVX. NewEdge Advisors LLC increased its position in shares of Enovix by 4.7% during the first quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock valued at $215,000 after purchasing an additional 1,853 shares during the period. Edgestream Partners L.P. raised its stake in shares of Enovix by 12.3% in the first quarter. Edgestream Partners L.P. now owns 229,286 shares of the company’s stock valued at $1,188,000 after purchasing an additional 25,159 shares in the last quarter. Amundi lifted its position in Enovix by 6.3% in the first quarter. Amundi now owns 254,160 shares of the company’s stock worth $1,317,000 after purchasing an additional 15,126 shares during the period. California State Teachers Retirement System lifted its position in Enovix by 49.8% in the first quarter. California State Teachers Retirement System now owns 253,039 shares of the company’s stock worth $1,311,000 after purchasing an additional 84,134 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in Enovix by 8.9% during the first quarter. The Manufacturers Life Insurance Company now owns 86,474 shares of the company’s stock worth $448,000 after buying an additional 7,075 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

See Also

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.